DrugDashboards

Dextrose

Dextrose Monohydrate · DEXTROSE MONOHYDRATE 50 g/1000mL · Injection, Solution · Intravenous · Baxter Healthcare Corporation

NDC 00338-0017-38 · 16 BAG in 1 POUCH / 100 mL in 1 BAG · NDA · View full market →

The short version

14 companies supply this market — deep enough that no single failure threatens the supply. It is in shortage right now — FDA lists the reason as “other”.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$2.57
Reported to Texas DSHS · 2026 annual filing · Baxter Healthcare Corporation

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$15,546
710 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA016673
TE code
AP
Approval date
Jan 1, 1982
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0074-30)Jul 20, 2026
    month 2 of a typical 20 for injectable shortages · model puts 26% odds it resolves within 6 months
  • In shortage now — DEXTROSE 70% IN PLASTIC CONTAINER, Injection, 70 g/100 mL (NDC 0990-7120-07)Oct 11, 2024
    month 23 of a typical 20 for injectable shortages · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose Monohydrate 70%, Injection, 70 g/100 mL (NDC 0338-0719-06)Oct 11, 2024
    Other
    month 23 of a typical 20 for injectable shortages · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-02)Mar 1, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-03)Mar 1, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-09)Mar 1, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-02)Mar 1, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-03)Mar 1, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-04)Mar 1, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-74)Mar 1, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-75)Mar 1, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-76)Mar 1, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0062-30)Feb 14, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0066-20)Feb 14, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0070-10)Feb 14, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0078-20)Feb 14, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-02)Feb 14, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-03)Feb 14, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-09)Feb 14, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-55)Feb 14, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months

Recalls (this NDC)

  • Class II · TerminatedJul 6, 2017
    Baxter Healthcare Corporation — Lack of Assurance of Sterility: Bags have the potential to leak.
  • Class I · TerminatedMar 24, 2015
    Baxter Healthcare Corp. — Presence of Particulate Matter: Products recalled due to presence of particulate matter (metal)
  • Class I · TerminatedMar 24, 2015
    Baxter Healthcare Corp. — Presence of Particulate Matter: Products recalled due to presence of particulate matter (metal)
  • Class II · TerminatedMar 18, 2015
    Baxter Healthcare Corp. — Lack of Assurance of Sterility. Complaints were receive of missing closures and/or leaks which may compromise product sterility.
  • Class I · TerminatedNov 21, 2013
    Baxter Healthcare Corp. — Presence of Paticulate Matter; Baxter is issuing a voluntary recall for these IV solutions due to particulate matter found in the solution identified as polyester and cotton fibers, adhesive-like mixture, polyacetal particles, thermally degraded PVC, black polypropylene and human hair embedded in the plastic bag
  • Class II · TerminatedMay 21, 2013
    Baxter Healthcare Corp. — Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port.

Manufacturers of Dextrose Monohydrate (Injection, Solution)

LabelerStrengthFirst seenLast seen
Baxter Healthcare CorporationDEXTROSE MONOHYDRATE 5 g/100mLJul 15, 2026Sep 3, 2026
Baxter Healthcare CorporationDEXTROSE MONOHYDRATE 2.5 g/50mLJul 15, 2026Sep 3, 2026
Fresenius Kabi Usa, LlcDEXTROSE MONOHYDRATE 50 mg/mLJul 15, 2026Sep 3, 2026
Henry Schein, Inc.DEXTROSE MONOHYDRATE 25 g/50mLJul 15, 2026Sep 3, 2026
ICU Medical, Inc.DEXTROSE MONOHYDRATE 5 g/100mLJul 15, 2026Sep 3, 2026
Medical Purchasing Solutions, LLCDEXTROSE MONOHYDRATE 25 g/50mLJul 15, 2026Sep 3, 2026
Baxter Healthcare CorporationDEXTROSE MONOHYDRATE 50 g/1000mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationDEXTROSE MONOHYDRATE 100 g/1000mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationDEXTROSE MONOHYDRATE 70 g/100mLJul 15, 2026Sep 2, 2026
Becton Dickinson and CompanyDEXTROSE MONOHYDRATE 100 mg/mLJul 15, 2026Sep 2, 2026
Becton Dickinson and CompanyDEXTROSE MONOHYDRATE 50 mg/mLJul 15, 2026Sep 2, 2026
Becton Dickinson And CompanyDEXTROSE MONOHYDRATE 2500 mg/50mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCDEXTROSE MONOHYDRATE 12500 mg/250mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCDEXTROSE MONOHYDRATE 5000 mg/100mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCDEXTROSE MONOHYDRATE 50 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCDEXTROSE MONOHYDRATE 2500 mg/50mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCDEXTROSE MONOHYDRATE 25000 mg/500mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCDEXTROSE MONOHYDRATE 100 mg/mLJul 15, 2026Sep 2, 2026
Hospira, Inc.DEXTROSE MONOHYDRATE 250 mg/mLJul 15, 2026Sep 2, 2026
Hospira, Inc.DEXTROSE MONOHYDRATE 50 mg/mLJul 15, 2026Sep 2, 2026
ICU Medical Inc.DEXTROSE MONOHYDRATE 70 g/100mLJul 15, 2026Sep 2, 2026
ICU Medical, Inc.DEXTROSE MONOHYDRATE 10 g/100mLJul 15, 2026Sep 2, 2026
International Medication Systems, LimitedDEXTROSE MONOHYDRATE 25 g/50mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCDEXTROSE MONOHYDRATE 250 mg/mLJul 15, 2026Sep 2, 2026
ProPharma DistributionDEXTROSE MONOHYDRATE 50 mg/mLJul 15, 2026Sep 2, 2026
ProPharma DistributionDEXTROSE MONOHYDRATE 25 g/50mLJul 15, 2026Sep 2, 2026
Remedyrepack Inc.DEXTROSE MONOHYDRATE 250 mg/mLJul 15, 2026Sep 2, 2026
Remedyrepack Inc.DEXTROSE MONOHYDRATE 25 g/50mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstDEXTROSE MONOHYDRATE 25 g/50mLJul 15, 2026Aug 29, 2026
Hospira, Inc.DEXTROSE MONOHYDRATE 25 g/50mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Dextrose — NDC 00338-0017-38," retrieved September 3, 2026, https://drugdashboards.com/drug/00338001738.

Free to cite with attribution — see how the data is put together.